Literature DB >> 28360595

Alterations of Lipid-Lipoprotein and Leptin in Bipolar Disorder Associated with Clinic Process.

Feridun Bülbül1, Ayşegül Giray Eryiğit2, A Binnur Erbağci2, Salih Selek3, Haluk Savaş1.   

Abstract

INTRODUCTION: Obesity is more common among patients with bipolar disorder as compared to normal population. There are studies showing increased leptin levels in obese patients. The aim of the present study was to investigate the alterations in leptin levels, body mass index (BMI), and lipid-lipoprotein levels during manic period, as well as during euthymic period, after one month in patients with bipolar disorder.
METHODS: Thirty-one adult patients, who had been hospitalized in the psychiatry clinic because of manic period of bipolar disorder, were included in the present study. Serum leptin and lipid-lipoprotein levels and BMI of the patients were analyzed both on the first day and 30th day of hospitalization after they became euthymic.
RESULTS: Total cholesterol and triglyceride levels significantly increased in male patients (p<.05). The increase in total cholesterol and LDL-C levels was not significant in female patients (p=.066 and p=.056, respectively). BMI was significantly, but slightly increased in both genders (.56±.14 kg/m2), however, such a change was not observed in serum leptin levels.
CONCLUSION: Results of the present study demonstrated that clinical improvement in bipolar patients showed different association in each gender with the alterations in BMI and serum lipid and/or lipoprotein levels. Such an alteration might have resulted from direct or indirect effect of drugs, as well as from lifestyle changes.

Entities:  

Keywords:  Bipolar disorder; body mass index; leptin; lipid-lipoprotein

Year:  2014        PMID: 28360595      PMCID: PMC5370263          DOI: 10.4274/npa.y6668

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  21 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  From lesions to leptin: hypothalamic control of food intake and body weight.

Authors:  J K Elmquist; C F Elias; C B Saper
Journal:  Neuron       Date:  1999-02       Impact factor: 17.173

3.  Plasma leptin in depressed patients and healthy controls.

Authors:  M Deuschle; W F Blum; P Englaro; U Schweiger; B Weber; C D Pflaum; I Heuser
Journal:  Horm Metab Res       Date:  1996-12       Impact factor: 2.936

4.  Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.

Authors:  Andrea Fagiolini; Ellen Frank; John A Scott; Scott Turkin; David J Kupfer
Journal:  Bipolar Disord       Date:  2005-10       Impact factor: 6.744

5.  Cholesterol levels in mood disorders: high or low?

Authors:  S N Ghaemi; G S Shields; J D Hegarty; F K Goodwin
Journal:  Bipolar Disord       Date:  2000-03       Impact factor: 6.744

6.  Weight gain and serum leptin levels in patients on lithium treatment.

Authors:  Murad Atmaca; Murat Kuloglu; Ertan Tezcan; Bilal Ustundag
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

7.  Prevalence of overweight and obesity in bipolar patients.

Authors:  J L Elmslie; J T Silverstone; J I Mann; S M Williams; S E Romans
Journal:  J Clin Psychiatry       Date:  2000-03       Impact factor: 4.384

Review 8.  Neuropeptide Y. A novel sympathetic stress hormone and more.

Authors:  Z Zukowska-Grojec
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

9.  Serum leptin and cholesterol levels in patients with bipolar disorder.

Authors:  Murad Atmaca; Murat Kuloglu; Ertan Tezcan; Bilal Ustundag; Yilmaz Bayik
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

10.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

View more
  1 in total

1.  Metabolomic and proteomic profiling in bipolar disorder patients revealed potential molecular signatures related to hemostasis.

Authors:  Henrique Caracho Ribeiro; Partho Sen; Alex Dickens; Elisa Castañeda Santa Cruz; Matej Orešič; Alessandra Sussulini
Journal:  Metabolomics       Date:  2022-08-03       Impact factor: 4.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.